CSIRO tells of sea shells that protect sensitive cures
A capsule inspired by the porous structure of seashells has been developed to protect drugs from extreme temperatures and could be used in controlled delivery.
Archives for June 8, 2015
Bio-Techne to push further into clinical diagnostic market with Cliniqa acquisition
Research and clinical diagnostic tool provider Bio-Techne has agreed to acquire Cliniqa, which specializes in the manufacturing and commercialization of quality controls and calibrators as well as bulk reagents used in the clinical diagnostic market....
Patheon looks to go public with $100m IPO
US-based contract development and manufacturing organization (CDMO) Patheon has registered with the SEC as part of plans to go public with an IPO that could be worth as much as $100m.
EMA calls for 'stakeholder' input on design of new clinical trials database
The EMA has called for input on the design of the public clinical trial database it is developing via a survey sent to "stakeholders."
Harvard professors question aspects of 21st Century Cures Act
The 21st Century Cures Act may actually offer the FDA too much discretion to approve drugs without conventional clinical trials, and in some cases “on the basis of less rigorous data,” two medicine professors from Harvard write in an editorial in the New...
Accuratus growing CDMO biz through Array Biopharma's CMC operations
Accuratus Lab Services has bought the chemistry, manufacturing and controls (CMC) operations of Array BioPharma to boost its CDMO offering.